Delta(9)-Tetrahydrocannabinol (THC) inhibited nitric oxide (NO.), prod
uction by mouse peritoneal macrophages activated by bacterial endotoxi
n lipopolysaccharide (LPS) and interferon-gamma (IFN)-gamma). Inhibiti
on of NO. production was noted at THC concentrations as low as 0.5 mu
g/mL, and was nearly total at 7 mu g/mL. Inhibition was greatest if TH
C was added 1-4 hr before induction of nitric oxide synthase (NOS) by
LPS and IFN-gamma, and declined with time after addition of the induci
ng agents. This suggested that an early step such as NOS gene transcri
ption or NOS synthesis, rather than NOS activity, was affected by THC.
Steady-state levels of mRNA for NOS were not affected by THC. In cont
rast, protein synthesis was inhibited as indicated by immunoblotting.
NOS activity was also decreased in the cytosol of cells pretreated wit
h THC. Addition of excess cofactors did not restore activity. Inhibiti
on of NO. production was greater at low levels of IFN-gamma, indicatin
g the ability of the cytokine to overcome inhibition. The effectivenes
s of various THC analogues, in decreasing order of potency, was Delta(
8)-THC > Delta(9)-THC > cannabidiol greater than or equal to 11-OH-THC
> cannabinol. The presumably inactive stereoisomer, (+)Delta(9)-THC,
and the endogenous ligand for cannabinoid receptors, anandamide, were
weakly inhibitory. Inhibition may be mediated by a process that depend
s partly on stereoselective receptors and partly on a nonselective pro
cess. LPS, IFN-gamma, hormone receptor agonists, and forskolin increas
ed macrophage cyclic AMP levels. THC inhibited this increase, indicati
ng functional cannabinoid receptors. Addition of 8-bromocyclic AMP inc
reased NO. 2-fold, and partially restored NO. production that had been
inhibited by THC. This occurred only under conditions of limited NOS
induction, suggesting that the effect of THC on cyclic AMP was respons
ible for only a small portion of the inhibition of NO. production.